Clinical Trials Directory

Trials / Conditions / HER2-positive Advanced Breast Cancer

HER2-positive Advanced Breast Cancer

10 registered clinical trials studyying HER2-positive Advanced Breast Cancer — 7 currently recruiting.

StatusTrialSponsorPhase
RecruitingHER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequ
NCT06595563
Jules Bordet InstitutePhase 2
RecruitingTrastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positiv
NCT07100600
Henan Cancer HospitalPhase 2
RecruitingTQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
NCT07047365
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Phase 3
RecruitingOpen-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
NCT06625775
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)Phase 1
Enrolling By InvitationT-DM1 Combined With CDK4/6 Inhibitor Ribociclib
NCT06481956
Zheng YabingPhase 2
Not Yet RecruitingDP303c in Patients With HER2-positive Advanced Breast Cancer
NCT05901935
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 3
RecruitingEfficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC
NCT05856383
Zhejiang Cancer Hospital—
UnknownRWS of Inetetamab HER2 Positive Advanced Breast Cancer
NCT04963608
Zhiyong Yu—
CompletedPyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer
NCT04903652
Tianjin Medical University Cancer Institute and HospitalPhase 2
UnknownThe Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer
NCT04185649
Bio-Thera SolutionsPhase 3